Claritev (NYSE:CTEV) Given Consensus Rating of “Moderate Buy” by Analysts

Shares of Claritev (NYSE:CTEV) have been assigned a consensus rating of “Moderate Buy” from the seven research firms that are currently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and five have assigned a buy recommendation to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $33.6667.

A number of brokerages recently issued reports on CTEV. Canaccord Genuity Group started coverage on shares of Claritev in a report on Friday, May 29th. They issued a “buy” rating and a $32.00 price objective for the company. Barclays initiated coverage on shares of Claritev in a research report on Friday, April 24th. They issued an “overweight” rating and a $28.00 price target for the company. Wall Street Zen downgraded shares of Claritev from a “hold” rating to a “sell” rating in a research note on Saturday, April 25th. Wells Fargo & Company cut their price target on shares of Claritev from $30.00 to $22.00 and set an “equal weight” rating on the stock in a report on Thursday, March 19th. Finally, Citigroup reissued a “buy” rating on shares of Claritev in a research note on Wednesday, May 13th.

Hedge Funds Weigh In On Claritev

A number of hedge funds have recently made changes to their positions in the stock. State of Wyoming bought a new stake in Claritev in the fourth quarter valued at approximately $25,000. Public Employees Retirement System of Ohio bought a new position in Claritev during the 1st quarter worth approximately $38,000. Ameritas Investment Partners Inc. acquired a new position in shares of Claritev in the 3rd quarter worth approximately $42,000. Legal & General Group Plc bought a new stake in shares of Claritev in the 3rd quarter valued at $45,000. Finally, Los Angeles Capital Management LLC bought a new stake in shares of Claritev in the 4th quarter valued at $45,000. 87.15% of the stock is currently owned by institutional investors.

Claritev Trading Down 4.0%

Claritev stock opened at $31.85 on Wednesday. The stock has a 50-day moving average price of $27.18 and a two-hundred day moving average price of $25.27. Claritev has a 12 month low of $11.50 and a 12 month high of $74.07. The company has a market capitalization of $543.04 million, a PE ratio of -1.84 and a beta of 0.69.

About Claritev

Claritev is a healthcare technology, data and insights company focused on improving affordability,  transparency and quality. Led by deeply experienced associates, data scientists, and innovators, Claritev provides tech-enabled solutions and services fueled by multiple data sources from over 40 years of claims repricing. Claritev utilizes world-class technology and AI solutions to power a robust enterprise platform that delivers meaningful insights to drive affordability in healthcare, brings price transparency and optimizes networks and benefits design.